SBC Medical Group Holdings Incorporated Revenue
SBC Medical Group Holdings Incorporated (SBC) reported Revenue of $49.19 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $49.19M, a 13.44% increase year-over-year.
- SBC Medical Group Holdings Incorporated revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $43.06M, a 9.02% decline year-over-year.
- SBC Medical Group Holdings Incorporated revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $39.57M, a 10.93% decline year-over-year.
- SBC Medical Group Holdings Incorporated revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $43.35M, a 18.33% decline year-over-year.
- SBC Medical Group Holdings Incorporated revenue from contract with customer, excluding assessed tax for fiscal 2025 was $173.61M, a 15.48% decline from fiscal 2024.
- SBC Medical Group Holdings Incorporated revenue from contract with customer, excluding assessed tax for fiscal 2024 was $205.42M, a 6.13% increase from fiscal 2023.
- SBC Medical Group Holdings Incorporated revenue from contract with customer, excluding assessed tax for fiscal 2023 was $193.54M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $49.19M 10-Q · filed 2026-08-13 | $92.25M 10-Q · filed 2026-08-13 | $131.82M derived: sum of 3 quarters · filed 2026-08-13 | $175.17M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $43.06M 10-Q · filed 2026-05-14 | $82.63M derived: sum of 2 quarters · filed 2026-05-14 | $125.98M derived: sum of 3 quarters · filed 2026-05-14 | $169.34M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $39.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $82.92M derived: sum of 2 quarters · filed 2026-03-27 | $126.28M derived: sum of 3 quarters · filed 2026-08-13 | $173.61M 10-K · filed 2026-03-27 |
| 2025-09-30 | $43.35M 10-Q · filed 2025-11-14 | $86.71M derived: sum of 2 quarters · filed 2026-08-13 | $134.04M 10-Q · filed 2025-11-14 | $178.46M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $43.36M 10-Q · filed 2026-08-13 | $90.69M 10-Q · filed 2026-08-13 | $135.11M derived: sum of 3 quarters · filed 2026-08-13 | $188.19M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $47.33M 10-Q · filed 2026-05-14 | $91.75M derived: sum of 2 quarters · filed 2026-05-14 | $144.83M derived: sum of 3 quarters · filed 2026-05-14 | $197.94M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $44.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $97.51M derived: sum of 2 quarters · filed 2026-03-27 | $150.61M derived: sum of 3 quarters · filed 2026-03-27 | $205.42M 10-K · filed 2026-03-27 |
| 2024-09-30 | $53.08M 10-Q · filed 2025-11-14 | $106.19M derived: sum of 2 quarters · filed 2025-11-14 | $161.00M 10-Q · filed 2025-11-14 | $223.34M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $53.10M 10-Q · filed 2025-08-13 | $107.91M 10-Q · filed 2025-08-13 | $170.26M derived: sum of 3 quarters · filed 2025-08-13 | $217.54M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $54.81M 10-Q · filed 2025-05-15 | $117.16M derived: sum of 2 quarters · filed 2025-05-15 | $164.44M derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $62.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $109.63M derived: sum of 2 quarters · filed 2025-03-28 | $193.54M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $47.28M 10-Q · filed 2024-11-13 | $131.19M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |